Supporters of the ban called it a huge win in the battle against prescription drug abuse.
It was also a bonus for Purdue Pharma, the company with the patent on crushable OxyContin.
That patent has expired but with the ruling the company will still hold the market for the drug.
The state of Kentucky was at the forefront of the movement due to their above average numbers of prescription drug abuse and deaths.
The crushable version of OxyContin was targeted because it allowed addicts to quickly snort or shoot the powder to get high faster.
Kentucky Attorney General Jack Conway released a statement saying he was “extremely pleased that the FDA heeded the bipartisan advice of state attorneys general and policymakers throughout Kentucky and elsewhere. To have allowed generic, crushable Oxycontin on the market would have been a serious step backwards in our efforts against opiate painkiller abuse.”
Purdue Pharma came up with a crush-resistant version of the drug in 2010.